Citius Oncology (CTOR) Prepaid Assets (2022 - 2026)

Citius Oncology (CTOR) has reported Prepaid Assets for 5 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Prepaid Assets rose 157.39% year-over-year to $2.8 million in Q2 2026; TTM through Jun 2026 was $2.8 million, a 157.39% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 50.69% from the prior year.
• Prepaid Assets was $2.8 million for Q2 2026 at Citius Oncology, down from $3.1 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $7.7 million in Q3 2023 and troughed at $25454.0 in Q4 2023.
• A 5-year average of $1.8 million and a median of $1.3 million in 2025 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets plunged 71.13% in 2023 and surged 10507.37% in 2024, its largest moves.
• Over 5 years, Prepaid Assets stood at $88169.0 in 2022, then sank by 71.13% to $25454.0 in 2023, then surged by 10507.37% to $2.7 million in 2024, then rose by 17.15% to $3.2 million in 2025, then fell by 10.49% to $2.8 million in 2026.
• The last three Prepaid Assets figures came in at $2.8 million (Q2 2026), $3.1 million (Q1 2026), and $3.2 million (Q4 2025), per Business Quant data.